A correction has been issued to a report in Aging Cell describing a non-canonical function for the necroptosis executioner protein MLKL in hepatocytes, where it contributes to mitochondrial dysfunction and cellular senescence in the aging liver. The underlying work positions MLKL as a driver of hepatic decline independent of its established role in programmed cell death. Corrections of this kind affect how the primary data should be cited and interpreted.
Key Points
- MLKL acts in hepatocytes beyond its canonical necroptosis function
- Hepatic MLKL linked to mitochondrial dysfunction and senescence
- Correction notice amends the original Aging Cell publication
Longevity Analysis
The liver carries much of the body's metabolic and clearance burden, and its mitochondrial capacity declines measurably with age. Identifying a cell-death protein that damages hepatocyte energy production without triggering cell death reframes where senescent burden in the liver originates and which targets might slow it. Accurate interpretation also depends on the published record being correct, which is why amendments to foundational mechanistic papers warrant attention before clinical extrapolation.
Original published by Wiley Aging Cell.